Entities / Company
Amarin (United Kingdom).
company in London, United Kingdom
- Reports this week
- 0
- Active events
- 0
- Connections
- 37
What's happening
One to three months ago
Gone quiet
No new reports in 90+ days-
Garrett Motion, Amarin, and Dorian LPG saw significant stock gains on June 27, 2025, with Zacks Investment Research providing strong buy ranks.Speculative1 report
-
A partnership was established to commercialize VAZKEPA in Europe via an exclusive license. Aaron Berg serves as President & CEO of Amarin.Well supported11 reports
-
Abbott Laboratories and Amarin are noted for outperforming peers in the Medical sector.Speculative1 report
-
Dexcom and Amarin were reported to be outperforming their respective sectors on July 21, 2025.Some support1 report
-
Analysts raised earnings estimates for Amarin, enhancing its prospects.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Amarin (United Kingdom) this week
News at the entities that move Amarin (United Kingdom) most-
Europe Shared contextA survey presented in Porto highlights the decline in European chemical output affecting the sector.Moves Amarin (United Kingdom)
-
Ireland Shared contextA New Hampshire native is running a culinary pop-up business in Ireland, promoting her food on Instagram.Moves Amarin (United Kingdom)
Connections
The 4 strongest of 37, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Aaron Berg Structural
Aaron Berg serves as the President & CEO of Amarin (United Kingdom).
-
Recordati Operational
Recordati and Amarin established a partnership for the exclusive licensing and commercialization of Vazkepa in the EU.
-
Europe Shared context
Amarin operates, maintains offices, and conducts sales and licensing deals within the European market.
-
Ireland Shared context
Amarin maintains offices within Ireland.
History
Events by the month they beganJune 2026
6 events- Trump's pledge to unleash American oil and gas is linked to US stocks and software companies Amarin and Salesforce.
- Garrett Motion, Amarin, and Dorian LPG saw significant stock gains on June 27, 2025, with Zacks Investment Research providing strong buy ranks.
- A partnership was established to commercialize VAZKEPA in Europe via an exclusive license. Aaron Berg serves as President & CEO of Amarin.
- Abbott Laboratories and Amarin are noted for outperforming peers in the Medical sector.
- Dexcom and Amarin were reported to be outperforming their respective sectors on July 21, 2025.
- Analysts raised earnings estimates for Amarin, enhancing its prospects.